The Commission has received official recovery and resilience plans from Denmark, Spain, Latvia and Luxembourg. The Recovery, Transformation and Resilience plan aims to provide €672.5 billion in loans and grants to support reforms and investments undertaken by Member States. The aim is to reduce the economic and social impact of the coronavirus pandemic and to […]
Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues
EMA’s safety committee (PRAC) is reviewing very rare cases of unusual blood clots that occurred in the United States following the use of Janssen’s COVID-19 vaccine. The type of blood clot reported, cerebral venous sinus thrombosis (CVST), occurred in most cases in combination with low levels of blood platelets (thrombocytopenia). The US FDA and CDC […]
SARS-CoV-2 mutations thwart body’s killer cells
An EU-backed study has shown that when the SARS-CoV-2 virus mutates, it can prevent killer T cells from recognising infected cells and eliminating them. In the ongoing battle against the SARS-CoV-2 virus, antibodies play a vital role in fighting off infection. However, they don’t work alone. Another protagonist is the killer T cell that finds […]
COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events
EMA is aware that the Danish Health Authority has paused its vaccination campaign with COVID-19 Vaccine AstraZeneca. This was decided as a precautionary measure while a full investigation is ongoing into reports of blood clots in people who received the vaccine, including one case in Denmark where a person died. Some other Member States have […]
HERA Incubator to anticipate the threat of COVID-19 variants
Von der Leyen announces the start of HERA Incubator to anticipate the threat of coronavirus variants To prepare Europe for an increased threat of coronavirus variants, the President of the European Commission Ursula von der Leyen announced the start of European bio-defence preparedness plan called “HERA Incubator”. The Health Emergency Preparedness and Response Authority (HERA) Incubator will […]
Norway and online classes due to Covid-19
Norway is moving into the new technological era. To avoid a high number of contagions, the Norwegian education system has taken advantage of the opportunities offered by digital media to allow students and teachers to continue teaching online. The country closed in March 2020, any educational activity was kept closed again to prevent the spread […]
Irregular migration into EU last year lowest since 2013 due to COVID-19
The number of detections of illegal border crossings along the EU’s external borders fell 13% last year to around 124 000, in large part due to the impact of COVID-19 restrictions put in place by various countries, according to preliminary figures collected by Frontex. This was the lowest number of illegal border crossings since 2013. […]
The University of Almeria, the first Andalusian university and the second in Spain to obtain certification from AENOR’s COVID-19
19, the first university in Andalusia and the second in Spain to achieve such a prestigious certification, demonstrating its total commitment to the protection of students, PAS and PDI. With great satisfaction the Management of the University of Almeria has received the notification coming from AENOR: it has been granted the Certification of Protocols in […]
EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by AstraZeneca and Oxford University. The assessment of the vaccine, known as COVID-19 Vaccine AstraZeneca, will proceed under an accelerated timeline. An opinion on the marketing authorisation could be issued by 29 January during the meeting of EMA’s scientific committee for human […]